Trafficking regulation of proteins in Alzheimer's disease

115Citations
Citations of this article
196Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The β-amyloid (Aβ) peptide has been postulated to be a key determinant in the pathogenesis of Alzheimer's disease (AD). Aβ is produced through sequential cleavage of the β-amyloid precursor protein (APP) by β- and γ-secretases. APP and relevant secretases are transmembrane proteins and traffic through the secretory pathway in a highly regulated fashion. Perturbation of their intracellular trafficking may affect dynamic interactions among these proteins, thus altering Aβ generation and accelerating disease pathogenesis. Herein, we review recent progress elucidating the regulation of intracellular trafficking of these essential protein components in AD. © 2014 Jiang et al.; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Jiang, S., Li, Y., Zhang, X., Bu, G., Xu, H., & Zhang, Y. W. (2014, January 11). Trafficking regulation of proteins in Alzheimer’s disease. Molecular Neurodegeneration. https://doi.org/10.1186/1750-1326-9-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free